These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2075353)

  • 1. [The clinical significance of disorders of humoral immunity in Sjögren's disease and syndrome].
    Kirtava ZZ
    Revmatologiia (Mosk); 1990; (4):35-41. PubMed ID: 2075353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of antinuclear antibody and other immunohematological profiles among primary Sjögren's syndrome, secondary Sjögren's syndrome associated with rheumatoid arthritis or systemic lupus erythematosus, and corresponding systemic disease.
    Ichikawa Y; Takaya M; Shimizu H; Uchiyama M; Moriuchi J; Morita K; Hoshina Y; Horiki T
    Tokai J Exp Clin Med; 1993 Dec; 18(3-6):133-8. PubMed ID: 7701526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus.
    Provost TT; Talal N; Harley JB; Reichlin M; Alexander E
    Arch Dermatol; 1988 Jan; 124(1):63-71. PubMed ID: 3257371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ro(SSA) and La(SSB) antibodies in the clinical spectrum of Sjögren's syndrome.
    Alexander EL; Hirsch TJ; Arnett FC; Provost TT; Stevens MB
    J Rheumatol; 1982; 9(2):239-46. PubMed ID: 7097683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome.
    Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM
    Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Association of systemic lupus erythematosus and Sjögren's syndrome].
    Szántó A; Kiss E; Sas A; Szegedi G; Zeher M
    Orv Hetil; 2005 Dec; 146(50):2533-8. PubMed ID: 16440498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases.
    Goules A; Tzioufas AG; Manousakis MN; Kirou KA; Crow MK; Routsias JG
    J Autoimmun; 2006 May; 26(3):165-71. PubMed ID: 16621447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sjögren's syndrome in systemic lupus erythematosus.
    Andonopoulos AP; Skopouli FN; Dimou GS; Drosos AA; Moutsopoulos HM
    J Rheumatol; 1990 Feb; 17(2):201-4. PubMed ID: 2319519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
    Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
    Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic secondary Sjögren's syndrome in patients with systemic lupus erythematosus (SLE). Relation to anti-SS-A and anti-SS-B autoantibodies.
    Jonsson H; Nived O; Sturfelt G; Norberg R
    Scand J Rheumatol Suppl; 1986; 61():166-9. PubMed ID: 3495873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.
    Hansen B; Manthorpe R
    Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The autoantibody profile in Sjögren's syndrome].
    Manoussakis MN; Pange PJ; Moutsopulos HM
    Ter Arkh; 1988; 60(4):17-20. PubMed ID: 3260689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Primary Sjögren's syndrome: clinical and immunologic study of 80 patients].
    Ramos M; Cervera R; García-Carrasco M; Miret C; Muñoz FJ; Espinosa G; Font J; Ingelmo M
    Med Clin (Barc); 1997 May; 108(17):652-7. PubMed ID: 9312582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Ro and La.
    Reichlin M
    Ann Med Interne (Paris); 1998 Feb; 149(1):34-41. PubMed ID: 11490515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pulse therapy in the complex treatment of severe forms of Sjögren's syndrome and disease].
    Vasil'ev VI; Solov'ev SK; Simonova MV; Safonova TN; Nasonov EL
    Ter Arkh; 1986; 58(7):117-22. PubMed ID: 3764727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis: anti-Ro antibodies define a non-HLA-DR4 associated clinicoserological cluster.
    Boire G; Ménard HA; Gendron M; Lussier A; Myhal D
    J Rheumatol; 1993 Oct; 20(10):1654-60. PubMed ID: 8295174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Ro/SSA and -La/SSB antibodies in patients with connective tissue diseases.
    Yamagata H; Akizuki M; Tojo T; Homma M
    Scand J Rheumatol Suppl; 1986; 61():98-101. PubMed ID: 3495876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sjögren's syndrome in systemic scleroderma].
    Guseva NG; Simonova MV; Kirtava ZZ; Shcherbakov AB
    Ter Arkh; 1988; 60(4):54-6. PubMed ID: 3394099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibodies against soluble nuclear antigens of the SS-A or SS-B type. Significance in systemic lupus erythematosis (author's transl)].
    Meyer O; Haim T
    Nouv Presse Med; 1981 Jun; 10(26):2179-84. PubMed ID: 6973748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.